ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1545

Vitamin D Insufficiency in Patients with Rheumatoid Arthritis and Healthy Controls and Correlation Between Vitamin D Levels and Disease Activity and Disability in RA Patients

Bhupendra Vaishnav1,2, Bhowmik Meghnathi1,3, Abhishek Patil1, Sundeep Upadhyaya1, S J Gupta1 and Rohini Handa1, 1Rheumatology, Indraprastha Apollo Hospitals, New Delhi, India, 2Rheumatology, Rajiv Gandhi Superspeciality Hospital, Delhi, India, 3Rheumatology B, Groupe Hospitalier Cochin-Saint Vincent de Paul, Paris, France

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Disability and rheumatoid arthritis (RA), Disease Activity, Vitamin D

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: Rheumatoid Arthritis – Clinical Aspects - Poster II: Co-morbidities and Complications

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Lower serum vitamin D levels have been shown to be associated with various autoimmune disorders including Rheumatoid Arthritis (RA). We undertook this study to evaluate vitamin D status and assess the relationship if any between vitamin D levels and disease activity and disability in patients with RA.

Methods: A total of 100 adult patients (82 females, 18 males) of RA (ACR/EULAR-2010 criteria) presenting to Rheumatology department and 50 healthy controls drawn from hospital staff matched for age and gender (42 female, 8 male) were enrolled. Exclusion criteria comprised severe hepatic, and/or renal disease, uncontrolled diabetes, granulomatous disease. Disease activity and disability was evaluated by DAS28(ESR) and Indian HAQ disability index (HAQ-DI) respectively. Serum total 25(OH)D3 levels were measured by electrochemiluminescence assay. Vitamin D insufficiency was defined as <30 ng/ml. Unpaired t-tests, chi square, ANOVA, Kruskal Wallis, Pearson and multivariate regression were applied as appropriate.

Results: The mean 25(OH)D3 levels in cases and controls were 28.29±16.67 and 15.59±10.58 ng/ml respectively (p-value=0.000). As many as 62% of the patients and 88% (44/50) of the controls had vitamin D insufficiency (p-value<0.001). Mean serum vitamin D levels were significantly higher in patients who were on high dose (oral 60,000 IU/week or injection within last 6 months) of vitamin D supplementation (40%) (39.55±17.00 ng/ml) (p-value<0.001) compared to that of those who had received either none (23%), 250 IU/day (23%) or 500 IU/day (14%). Vitamin D levels were not significantly different in patients who were in remission, low, moderate and high disease activity (27.05±15.05, 32.44±18.52, 27.49±17.30 and 32.88±27.75 ng/ml respectively, p-value=0.709). No significant correlation was seen between mean vitamin D levels and age, BMI, SJC, TJC, ESR, General Health (GH), DAS28(ESR), HAQ-DI and serum PTH. Only duration of illness was positively correlated with vitamin D level (r=0.212, p-value=0.035). Vitamin D levels were also not different with regard to gender, menopause, deformity, hypothyroidism, RF, anti CCP status and current glucocorticoid use. On multivariate analysis, vitamin D levels were not related to various disease activity and disability variables [SJC, TJC, ESR, GH, DAS28(ESR) and HAQ-DI].  

WR0

Conclusion: Vitamin D insufficiency was widespread both in patients with RA (62%) and in hospital staff without any disease (88%). No correlation was found between mean 25(OH)D3 levels and disease activity, disability and other variables. Longer disease duration of RA was associated with higher vitamin D levels. This could be because of greater use of vitamin D supplements by patients with long standing disease. The healthy hospital staff had low vitamin D possibly due to greater time spent indoors.    


Disclosure: B. Vaishnav, None; B. Meghnathi, None; A. Patil, None; S. Upadhyaya, None; S. J. Gupta, None; R. Handa, None.

To cite this abstract in AMA style:

Vaishnav B, Meghnathi B, Patil A, Upadhyaya S, Gupta SJ, Handa R. Vitamin D Insufficiency in Patients with Rheumatoid Arthritis and Healthy Controls and Correlation Between Vitamin D Levels and Disease Activity and Disability in RA Patients [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/vitamin-d-insufficiency-in-patients-with-rheumatoid-arthritis-and-healthy-controls-and-correlation-between-vitamin-d-levels-and-disease-activity-and-disability-in-ra-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/vitamin-d-insufficiency-in-patients-with-rheumatoid-arthritis-and-healthy-controls-and-correlation-between-vitamin-d-levels-and-disease-activity-and-disability-in-ra-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology